Document:

Form of Separation and Release Agreement

 Exhibit 10.2 
 EXECUTION VERSION 
 SEPARATION AND RELEASE
AGREEMENT 
 This SEPARATION AND RELEASE AGREEMENT (this “Agreement”) is entered into as of October 2,
2012, by and between Innovaro, Inc., a Delaware corporation (the “Company”) and              (“Employee”). 

RECITALS 
 WHEREAS, the Company will sell certain assets and license certain other assets of its Strategos branded consulting business (the “Consulting Business”) to Strategos, Inc. (“New
Strategos”) pursuant to that certain Asset Purchase Agreement dated October 2, 2012 (the “Purchase Agreement”) and that certain Technology License Agreement dated October 2, 2012 (the “License
Agreement”); 
 WHEREAS, employees of the Company working in the Consulting Business will resign (collectively, the
“Strategos Employees”), including Employee; 
 AGREEMENT 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby
agree as follows: 
  

	1.	Separation. 

 Employee’s
employment with the Company will end effective August 31, 2012 (the “Separation Date”), which will be Employee’s last day of work. 
  

	2.	Unpaid Compensation and Benefits. 

As of the Separation Date, the Company owes Employee the following compensation and benefits and other obligations (collectively, the
“Combined Obligations”): 
 2.1 Accrued Salary and Vacation. On the Separation Date, the Company
will owe Employee all accrued base salary and all accrued and unused vacation listed on Schedule A, earned through the Separation Date (if any), subject to standard payroll deductions and withholdings. 

2.2 Expense Reimbursements. Employee acknowledges and agrees that all requests for expense reimbursement reflecting all business
expenses Employee incurred through the Separation Date, if any, have been submitted and any outstanding reimbursements are listed on Schedule A. 
 2.3 Bonuses and Other Compensation. The parties acknowledge and agree that the Company owes, but has not paid, Employee: (a) $         as a bonus for
2011; (b) $         for interest earned due to the delayed payment of 2012 wages; and (c) $         for interest earned due to the delayed payment of the 2011
bonus (collectively, the “Bonus Obligations”). 

  
 1 

 EXECUTION VERSION 

 

	3.	Payment. 

 In full and complete
satisfaction of the Combined Obligations, the Company agrees to make the following payments which Employee acknowledges are in full satisfaction of the net obligations in Section 2.1, less standard payroll deductions and withholdings as
noted in Section 2.1, and the obligations owed in Section 2.2: 
 3.1 Cash Payment. On or
before the closing of the Purchase Agreement and License Agreement, the Company will pay Employee $         in cash. 
 3.2 Assigned Payment. On or before the closing of the Purchase Agreement and License Agreement, the Company shall assign $        , of the Combined
Obligations to New Strategos and such amount shall be set off, in part, against payments made by New Strategos to the Company for acquiring the Consulting Business’ assets (the “Assigned Amount”) as set forth in the Purchase
Agreement. 
  

	4.	Corporate Interest Payout. 

 The parties
acknowledge and agree that the Company has sold, or agreed to sell, a business division besides the Consulting Business, within the calendar day period prior to the Separation Date (the “Existing Division”), and that the Company
will pay Employee $         out of the net proceeds received by the Company for the sale of an Existing Division upon the closing of such sale. 

 

	5.	Return of Company Property. 

Employee represents and warrants that as of the Separation Date Employee has returned all property belonging to the Company, except property transferred
to Strategos, Inc., which has been either acquired or licensed pursuant to the Purchase Agreement or License Agreement, respectively, or as otherwise provided for in this Agreement. Employee will not retain, without the Company’s express
consent, any copies of any of the Company’s PowerPoints, PDFs, memoranda, notes, plans, records, reports, computer tapes, printouts and software and other documents and data relating to the business of the Company and/or its subsidiaries and
affiliates, whether any of the foregoing constitute proprietary and confidential information, which are the property of the Company, and Employee warrants that Employee has returned to the Company, or destroyed, all copies of the foregoing documents
and material prior to the signing of this Agreement. 
  

	6.	Confidentiality. 

 6.1
Confidential Information Obligations. Employee acknowledges and reaffirms Employee’s continuing obligations under Employee’s Employment Agreement, a copy of which is attached as Exhibit A. 

6.2 Confidentiality. The provisions of this Agreement shall be held in strictest confidence by Employee and shall not be
publicized or disclosed in any manner whatsoever; provided, however, that: (a) Employee may disclose this Agreement in confidence to Employee’s immediate family; (b) Employee may disclose this Agreement in confidence to
Employee’s attorneys, accountants, auditors, tax preparers, and financial advisors; and 

  
 2 

 EXECUTION VERSION 

 
 
(c) Employee may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. By way of example, but not limitation, Employee
agrees not to disclose or discuss this Agreement with any current or former Company employee or independent contractor. 
  

	7.	Affirmative Covenants. 

7.1 Nondisparagement. Employee agrees not to disparage the Company, and the Company’s officers, directors, employees,
shareholders and agents, in any manner likely to be harmful to them or their business, business reputation or personal reputation; provided that Employee may respond accurately and fully to any inquiry or request for information in a government
investigation or as required by compulsion of law (including as required by a subpoena). 
 7.2 Cooperation and
Assistance. Employee agrees that Employee will not voluntarily provide assistance, information or advice, directly or indirectly (including through agents or attorneys), to any person or entity in connection with any claim or cause of action of
any kind brought against the Company, nor shall Employee induce or encourage any person or entity to bring such claims. Further, Employee agrees to voluntarily cooperate with the Company if Employee has knowledge of facts relevant to any threatened
or pending litigation against the Company by making Employee reasonably available without further compensation for interviews with the Company or its legal counsel, for preparing for and providing deposition testimony, and for preparing for and
providing trial testimony. 
  

	8.	Release of Claims. 

8.1 General Release. In consideration for executing this Agreement and other good and valuable consideration exchanged between the
parties, Employee, for Employee and for Employee’s heirs, assigns and personal representatives, do hereby waive, and release the Company, and its successors, affiliates, assigns and its respective officers, directors, shareholders, of and from
any and all claims, actions, causes of action, rights, suits, demands, obligations, and/or liabilities, joint or several, present, past or future, known or unknown, of whatever description, both at law and in equity, including, without limitation,
all claims of unpaid bonuses, prior asset sale proceed claims, employment discrimination, unjust or improper dismissal or treatment, intentional or negligent torts, retaliation, back pay, front pay, injuries, damages, reinstatement, future
employment opportunities, as well as any other claims related to Employee’s employment or separation from employment with the Company, which they may now have or may ever have had, including without limitation, any claims which may be made by
them or on their behalf under Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 1981, the Equal Pay Act, the Fair Labor Standards Act, the Americans With Disabilities Act, and/or the Family and Medical Leave Act, with the exception of any
claims arising out of the Company’s obligations under this Agreement. Employee represents and warrants that Employee does not have any current charge, claim, or lawsuit pending against the Company in any court or before any administrative body.

 (a) In particular, upon execution of this Agreement, Employee, does hereby waive and release the Company, and its
successors, affiliates, assigns and its respective officers, directors, shareholders, of and from any wage and have claim Employee may now have or may ever have had against the Company. 

  
 3 

 EXECUTION VERSION 

 
 (b) In consideration for execution of this Agreement
and other good and valuable consideration exchanged between the parties, the Company, for itself, its successors and assigns, does hereby waive, and release Employee, and Employee’s heirs, assigns and personal representatives, of and from any
and all claims, actions, causes of action, rights, suits, demands, obligations, and/or liabilities, joint or several, present, past or future, known or unknown, of whatever description, both at law and in equity, including, without limitation, which
it may now have or may ever have had, with the exception of any claims arising out of Employee’s obligations under this Agreement. 
 8.2 Waiver of Unknown Claims. In giving the releases set forth in this Agreement, which include claims which may be unknown to Employee at present, Employee acknowledges that Employee has read and
understands Section 1542 of the California Civil Code which reads as follows: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release,
which if known by him or her must have materially affected his or her settlement with the debtor.” Employee hereby expressly waives and relinquishes all rights and benefits under that section and any law or legal principle of similar effect
in any jurisdiction with respect to Employee’s release of claims herein, including but not limited to the release of unknown and unsuspected claims. 
  

	9.	Miscellaneous 

 9.1
Dispute Resolution. To aid in the rapid and economical resolution of any disputes which may arise under this Agreement, Employee and the Company agree that any and all claims, disputes or controversies of any nature whatsoever arising from or
regarding the interpretation, performance, negotiation, execution, enforcement or breach of this Agreement, Employee’s employment, or the termination of Employee’s employment, including but not limited to statutory claims (collectively,
“Claims”), shall be resolved to the fullest extent permitted by law, before a single arbitrator in Tampa, Florida. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of all Claims and
to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator’s essential findings and conclusions and a statement of the award. Employee and the Company acknowledge
that, by agreeing to this arbitration procedure, both Employee and the Company waives the right to resolve any Claims through a trial by jury or judge or by administrative proceeding. Nothing in this Agreement shall prevent either Employee or
the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of
any competent jurisdiction. 
 9.2 Entire Agreement. This Agreement, together with the Purchase Agreement, the License
Agreement and all schedules and exhibits attached hereto and thereto, constitute the entire agreement of the parties hereto regarding the separation and release, and all prior agreements, understandings, representations and statements, oral or
written, are superseded hereby. 

  
 4 

 EXECUTION VERSION 

 
 9.3 Captions. Section captions used in this Agreement
are for convenience only, and do not affect the construction of this Agreement. 
 9.4 Counterpart Execution. This
Agreement may be executed in one or more counterparts, each of which shall be deemed an original and all of which shall together constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Agreement by
facsimile transmission shall be effective as delivery of a manually executed counterpart thereof and shall be deemed an original signature for all purposes. 
 9.5 No Admissions. The promises and payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by either party to the other party, and
neither party makes any such admission. 
 9.6 Construction. The parties hereto have participated jointly in the
negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. Any reference to any federal, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder,
unless the context requires otherwise. The word “including” means “including without limitation”. 
 9.7
Successor and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties named herein and their respective successors and permitted assigns. No party may assign its rights or interests hereunder without providing the
other party with prior written notice. No party may delegate all or any of its obligations or duties hereunder, without the prior written consent of the other party. 
 9.8 Severability. If any provision of this Agreement is unenforceable, such provision will be changed and interpreted to accomplish the objectives of such provision to the greatest extent possible
under applicable law and the remaining provisions will continue in full force and effect. 
 9.9 Amendments and Waivers.
No amendment of any provision of this Agreement shall be valid unless the same shall be in writing and signed by the parties. No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether
intentional or not, shall be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.

 9.10 Governing Law. This Agreement shall be governed by and interpreted in accordance with the internal laws of the
State of Florida (without reference to conflicts of law principles). 
 [Signature Page Follows] 

  
 5 

 EXECUTION VERSION 

 
 IN WITNESS WHEREOF, the Company and Employee have caused this
Agreement to be executed as of the day and year first above written. 
  

			
	INNOVARO, INC.
		
	By:	 	 /s/ Asa Lanum

		
	Its:	 	 Chief Executive Officer

		
	By:	 	  

		
	Name:	 	  

  
 6 

 EXECUTION VERSION 

 
 SCHEDULE A 

UNPAID COMPENSATION 
  

					
	 Salary:
	  	 	None	  
		
	 Paid Time Off:
	  	$	            	  
		
	 Expenses:
	  	 	None	  
		
	 Other:
	  	 	None	  

  
 7Technology License Agreement

 Exhibit 10.3 
 TECHNOLOGY LICENSE AGREEMENT 
 This TECHNOLOGY LICENSE AGREEMENT (this
“Agreement”) is entered into as of October 2, 2012 (the “Effective Date”) by and between Innovaro, Inc., a Delaware corporation (“Licensor”) and Strategos, Inc., a Delaware corporation
(“Licensee”) for the purpose of granting Licensee a limited license to use certain intellectual property furnished by Licensor. 
 RECITALS 
 WHEREAS, Licensor has determined
to sell to Licensee certain assets of its Strategos branded consulting business (the “Consulting Business”) and to license to Licensee certain intellectual property owned by Licensor and used in connection with the Consulting
Business; 
 AGREEMENT 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Licensor and Licensee
hereby agree as follows: 
  

	1.	DEFINITIONS. As used in this Agreement: 

 1.1 “Affiliate” means, with respect to a party, any person or entity that controls, is controlled by, or is under common control with such party, where “control” means ownership
of fifty percent (50%) or more of the outstanding voting securities (but only as long as such person or entity meets these requirements). 
 1.2 “Improvement” means any improvement, modification, enhancement and/or derivative work of the Licensed Technology, and all Intellectual Property Rights in any such
improvement, modification, enhancement and/or derivative work, that is created, developed, licensed or acquired by Licensee after the Effective Date.  
 1.3 “Intellectual Property Rights” mean collectively, any and all now known or hereafter known tangible and intangible intellectual property rights or similarly protected rights in any
country, now or in the future, whether or not registered or perfected, and whether arising by operation of law, contract, license, or otherwise, of technical information, data and processes whether tangible or intangible, including, without
limitation: (i) copyrights, inventor certificates, and other rights associated with works of authorship throughout the world, including but not limited to, copyrights and moral rights (including the right of an author to be known as the author
of a work); (ii) know-how, processes, principles, conceptual frameworks, and trade secret rights; (iii) patent rights; (iv) rights related to designs, algorithms, semiconductor mask work rights; (v) trademark rights, trademark
and service mark rights (whether arising under common law or registered under state or federal law), trade names, and brand names and similar rights; and (v) to the extent applicable, all registrations, initial applications, renewals,
extensions, continuations, continuations-in-part, divisions or reissues hereof now or hereafter in force, including any rights in any of the foregoing. 
 1.4 “Licensed Technology” means the technology as represented and set forth and described in Exhibit A, including all Intellectual Property Rights embodied in or
owned in such technology, to the extent owned or licensed by Licensor. The Licensed Technology shall not 

  
 1 

 
include LaunchPad or any digital or physical material related to LaunchPad, including without limitation, PowerPoints and editable PDFs (collectively, “LaunchPad”), and any valid
use of LaunchPad by Licensee shall be governed by a separate agreement. 
  

	2.	LICENSE GRANT. 

 Licensor hereby grants to Licensee, for the sole and only purpose of management consulting and related activities (other than any activities related to automation of the Licensed Technology or the
development of software), an exclusive, fully transferable, sublicenseable, worldwide, perpetual right and license, under all of Licensor’s Intellectual Property Rights, to: (i) make, have made, use, distribute, transmit
(electronically or otherwise), sell, offer for sale, import, and transfer the Licensed Technology; (ii) use, modify, perform, display, create derivative works of, reproduce and copy the Licensed Technology for any purpose whatsoever, including,
without limitation, creating Improvements and designing, making, having made, using, offering to sell, selling, distributing, and importing the Licensed Technology; and (iii) sublicense the foregoing rights (with the right of further
sublicenses to multiple tiers of sublicensees). Notwithstanding anything contained herein to the contrary, Licensee agrees that it shall not grant any third party the right to develop, any software based on, or incorporating any element of, the
Licensed Technology.
 For purposes of clarity, if the Licensed Technology is incorporated in the existing or replacement DiscoverySpace
software, ownership of the DiscoverySpace software code may not be assigned or sold whether by direct sale, merger, sale of assets, sale of stock, or otherwise without written consent of Licensor. Licensee shall not incorporate the Licensed
Technology into software that operates as Launch Pad. 
 Licensee grants to Licensor a non-exclusive royalty free, perpetual, transferable,
license to utilize any Improvements to or Improvements of the Licensed Technology made by Licensee, which Licensor may utilize for the sole purpose of incorporating into its software products and selling its software products, provided that Licensor
may not assign such license without Licensee’s written consent, except pursuant to a transfer of all or substantially all of Licensor’s business and assets, whether by merger, sale of assets, sale of stock, or otherwise. Such license shall
be, and is, granted under all of Licensee’s Intellectual Property Rights, to: (i) make, have made, use, distribute, transmit (electronically or otherwise), sell, offer for sale, import, and transfer the Improvements solely within
Licensor’s proprietary software products; (ii) use, modify, perform, display, create derivative works of, reproduce and copy the Improvements solely within Licensor’s proprietary software products, including, without limitation,
creating Improvements and designing, making, having made, using, offering to sell, selling, distributing, and importing the Improvements solely as incorporated within Licensor’s proprietary software products. 

 

	3.	DELIVERY. 

3.1 Delivery of Technology. Within ten (10) days after the Effective Date, Licensor shall deliver to Licensee one
(1) copy of each component of the Licensed Technology in such formats as are set forth or contemplated in Exhibit A or as the parties may otherwise agree. 

  
 2 

 3.2 No Delivery of Improvements. Licensee shall deliver to Licensor any Improvement,
or any documentation or technical specifications developed by Licensee with respect thereto, upon reasonable request by Licensor. The rights to improvements, derivatives, products, and services based on the Licensed Technology will be owned by
Licensee. Licensee shall be entitled to establish all proprietary rights for itself in the Improvements, whether in the nature of trade secrets, copyrights, patents or other rights. Any copyright registration by Licensee for Improvements shall give
full attribution to Licensor’s copyrights, except as provided for in Section 2. 
  

	4.	LICENSE FEES AND PAYMENT.  

 

	 	4.1	Royalty. 

 (a)
Commencing on the Effective Date and ending on December 31, 2015, Licensee agrees to pay Licensor a twelve and one-half percent (12.5%) quarterly royalty on all professional fee revenues earned by Licensee over and above the first $10
million in professional fees earned by Licensee between the Effective Date and December 31, 2015 (the “License Fees”). Professional fee revenues will not include: (a) direct project expenses (e.g. travel) that are passed
through directly to clients; (b) fees and expenses for contracted services (e.g. faculty/Hamel professional fees, design firm fees, honoraria to speakers) that are passed through directly to clients without markup; and (c) fees and
expenses paid to Licensor for software or services/work products. However, other external payments (e.g. faculty/Hamel attribution payments) are included in professional fee revenues. The License Fees include all applicable sales, use, and other
taxes and all applicable export and import fees, customs duties and similar charges, and Licensor will be responsible for payment of all such taxes (other than taxes based on Licensor’s income), fees, duties, and charges, and any related
penalties and interest, arising from the payment of the License Fees or the delivery or license of the Licensed Technology to Licensee. 
 (b) On the six month anniversary of the Effective Date, and the expiration of each six month period thereafter, Licensee shall prepare and deliver to Licensor a written statement (a
“Calculation Statement”) containing Licensee’s calculation of all Royalties due to Licensor under this Section 4.1 with respect to such six month period along with a check in an amount equal to the amount set forth on such
Calculation Statement. 
 (c) Licensee shall maintain complete and accurate records regarding all professional fee
revenues earned by Licensee and all Royalties, and shall retain such records for a period of at least two years. During such period, all such records shall be made available for inspection and copying by Licensor (or Licensor’s designee) at
Licensor’s expense during normal business hours upon at least five business day’s prior notice to Licensee. Licensor may cause such records of Licensee to be audited at Licensor’s expense upon reasonable notice. If any inspection or
audit reveals a deficiency in the amounts paid to Licensor under this Section 4.1 for any period under audit (an “Audit Deficiency”), Licensee shall pay such Audit Deficiency within five business days of Licensor’s notice to
Licensee of the Audit Deficiency. If the Audit Deficiency is five percent (5%) or more of the aggregate amount paid to Licensor for such audit period, Licensee shall also reimburse Licensor for all costs and expenses incurred by Licensor in
connection with such audit. 

  
 3 

 4.2 Payment. Licensor acknowledges and agrees that it may never receive any License
Fees under this Agreement, and in no way does Licensee guarantee that Licensor will ever receive any such License Fees. All payments hereunder will be payable in U.S. dollars and made by wire transfer to a bank and account designated in writing by
Licensor. 
  

	5.	WARRANTIES. 

5.1 Authority. Each party hereby represents and warrants that: (i) it is duly organized, validly existing and in good standing
under the laws of its jurisdiction of incorporation; (ii) it has the legal right and authority to enter into and perform its obligations under this Agreement; (iii) the execution and performance of this Agreement will not conflict with or
violate any provision of any law having applicability to such party; and (iv) this Agreement, when executed and delivered, will constitute a valid and binding obligation of such party and will be enforceable against such party in accordance
with its terms. Licensor represents and warrants that as of the Effective Date, and to the best of its knowledge, the Licensed Technology, or any part thereof, does not infringe the Intellectual Property Rights of any third party. 

5.2 No Warranty of Merchantability or Fitness. Licensor hereby disclaims any express or implied warranty or representation as to
the scope or validity of the Licensed Technology. With the exception of the representations made in this Section, Licensor will disclaim and Licensee waives all warranties, whether express or implied, including, without limitation, all implied
warranties of merchantability or fitness for a particular purpose. 
  

	6.	INFRINGEMENT CLAIMS.  

 6.1 Licensor may elect, in its sole and absolute discretion, to defend at its own expense any action against Licensee brought by a third party to the extent that the action is based upon a claim
that only the Licensed Technology directly infringes any U.S. copyrights or misappropriates any trade secrets recognized as such under the Uniform Trade Secret law. If Licensor elects to defend such action, Licensor will pay those costs and damages
finally awarded against Licensee in any such action that are specifically attributable to such claim or those costs and damages agreed to in a monetary settlement of such action. Licensee shall notify Licensor promptly in writing of such action. In
the event that Licensor elects to defend such action, (i) Licensee shall give Licensor sole control of the defense thereof and any related settlement negotiations, (ii) Licensee shall cooperate with Licensor and, at Licensor’s request
and expense, assisting in such defense, (iii) Licensor shall have the option to settle any such dispute or institute a suit, if necessary, by counsel of Licensor’s choice, under Licensor’s control, and at Licensor’s expense, and
(iv) Licensee shall cooperate fully and otherwise provide proper assistance to Licensor, at no expense to Licensee. 

6.2 In the event that Licensor or Licensee become aware of any material competition by any unlicensed third party selling or
providing management consulting or related services utilizing the Licensed Technology, Licensor shall promptly take all action necessary to enforce its rights to the Licensed Technology and cause such competition to cease, including settling any
dispute which arises and instituting suit, if necessary, by counsel of Licensor’s choice, under Licensor’s control, and at Licensor’s expense, and, Licensee shall cooperate fully and otherwise

  
 4 

 
provide proper assistance to the Licensor, at no expense to Licensee. No settlement dispute reached by Licensor may be in violation of the exclusive license right granted to Licensee in
Section 2. Nothing in this Paragraph 6 shall be deemed to limit the obligations of Licensor under Section 9.4. 
 6.3 Licensee shall have the right, but not the obligation, to pursue any enforcement of the Licensed Technology against third-party infringers at the cost of Licensee. Licensor will reasonably
cooperate with Licensee in such enforcements, including joining as an indispensable party. Licensee will be responsible for all out-of-pocket costs, expenses, and legal fees incurred by each of Licensee and Licensor in connection with enforcing or
defending any claim (including without limitation counterclaims), suit, or action against such third party infringer initiated by Licensee, including without limitation all such costs, expenses and legal fees that may be incurred by Licensee or
Licensor with respect to a counter-claim filed by the infringing third party under a claim made by Licensee. 
  

	7.	LIMITATION OF LIABILITY. 

 IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY INCIDENTAL, INDIRECT, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, REGARDLESS OF THE NATURE OF THE CLAIM, INCLUDING, WITHOUT LIMITATION, LOST
PROFITS, COSTS OF DELAY, ANY FAILURE OF DELIVERY, BUSINESS INTERRUPTION, COSTS OF LOST OR DAMAGED DATA OR DOCUMENTATION OR LIABILITIES TO THIRD PARTIES ARISING FROM ANY SOURCE, EVEN IF THE PARTY FROM WHICH SUCH DAMAGES ARE SOUGHT HAS BEEN ADVISED OF
THE POSSIBILITY OF SUCH DAMAGES. 
  

	8.	TERM AND TERMINATION. 

 8.1 Term. The term of this Agreement will begin on the Effective Date and will continue indefinitely unless terminated pursuant to Section 8.2. 

8.2 Termination. Licensee may terminate this Agreement at any time, with or without cause, upon written notice to Licensor.
Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, if Licensee fails to pay any portion of the License Fees when due within twenty (20) days after receiving written notice from Licensor that payment is
due. 
 8.3 Effects of Termination. Upon termination or expiration of this Agreement for any reason, any amounts owed to
Licensor under this Agreement before such termination or expiration will be immediately due and payable, all licensed rights granted in this Agreement will immediately cease to exist, and Licensee must promptly discontinue all use of the Licensed
Technology and immediately return to Licensor the Licensed Technology. 
  

	9.	GENERAL. 

9.1 Proprietary Rights. The Licensed Technology and all worldwide Intellectual Property Rights therein, are the exclusive property
of Licensor. All rights in and to the Licensed Technology not expressly granted to Licensee in this Agreement are reserved by Licensor. 

  
 5 

 9.2 No Maintenance or Support. Licensor is not required to provide any maintenance or
support services with respect to the Licensed Technology under this Agreement. 
 9.3 Compliance with Laws. Licensee
acknowledges that the laws and regulations of the United States restrict the export and re-export of commodities and technical data of United States origin, including the Licensed Technology. Licensee agrees that it will not export or re-export the
Licensed Technology in any form in violation of the export or import laws of the United States or any foreign jurisdiction. Licensee will defend, indemnify, and hold harmless Licensor from and against any violation of such laws or regulations by
Licensee or any of its agents, officers, directors, or employees. 
 9.4 Assignments; Sublicenses. Licensee may assign or
transfer, by operation of law or otherwise, any of its rights under this Agreement to any third party, including Licensee’s Affiliates, without Licensor’s prior written consent, provided, however, that the assignee or
sublicensee thereof, agrees in writing that the rights being granted to such assignee or sublicensee, as the case may be, are limited to, and do not exceed the rights granted to Licensee under this Agreement. Licensee agrees that in the event that
Licensor or Licensee becomes aware that any assignee or sublicensee is in breach of its obligations to Licensee, or is otherwise making unlawful use of the Licensed Technology, Licensee shall promptly take all action necessary to cause such breach
to cease, at no expense to Licensor. This Agreement shall survive any merger, sale of assets, sale of stock or otherwise. 

9.5 Notices. All notices, consents, and approvals under this Agreement must be delivered in writing by courier, by electronic
facsimile (fax), or by certified or registered mail, (postage prepaid and return receipt requested) to the other party at the address set forth beneath such party’s signature, and will be effective upon receipt. Either party may change its
address by giving notice of the new address to the other party. 
 9.6 Governing Law and Venue. This Agreement will be
governed by the laws of the State of Florida. Any action or proceeding arising from or relating to this Agreement shall be brought in a federal or state court in Hillsborough County, Florida, and each party irrevocably submits to the jurisdiction
and venue of any such court in any such action or proceeding. 
 9.7 Waivers. All waivers must be in writing. Any waiver
or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of any other provision or of such provision on any other occasion. 
 9.8 Severability. If any provision of this Agreement is unenforceable, such provision will be changed and interpreted to accomplish the objectives of such provision to the greatest extent possible
under applicable law and the remaining provisions will continue in full force and effect. 
 9.9 Confidentiality of
Agreement. Neither party will disclose any terms of this Agreement to anyone other than its Affiliates, attorneys, accountants, and other professional advisors except (a) as required by law or (b) pursuant to a mutually agreeable press
release or (c) in connection with a contemplated transfer of such party’s business and this Agreement permitted by Section 9.4 (provided that any third party to whom the terms of this Agreement are to be disclosed signs a
confidentiality agreement reasonably satisfactory to the other party). 

  
 6 

 9.10 Construction. The headings of Sections of this Agreement are for convenience and
are not to be used in interpreting this Agreement. As used in this Agreement, the word “including” means “including but not limited to”. 
 9.11 Counterparts. This Agreement may be executed in counterparts, each of which will be considered an original, but all of which together will constitute the same instrument. 

9.12 Entire Agreement. This Agreement constitutes the entire agreement between the parties regarding the subject of this Agreement
and supersedes all prior or contemporaneous agreements, understandings, and communication, whether written or oral. This Agreement may be amended only by a written document signed by both parties. 

9.13 Attorneys’ Fees. Should any party hereto institute any action or proceeding in court or otherwise to enforce or
interpret this Agreement by reason of or with respect to an alleged breach of any provision hereof, the prevailing party shall be entitled to receive from the non-prevailing party such amount as the court may judge to be reasonable attorneys’
and paralegals’ fees for the services rendered to the prevailing party in such action or proceeding, plus the prevailing party’s costs and expenses therein, regardless of whether such action or proceeding is prosecuted to judgment.

 [Signature Page Follows] 

  
 7 

 IN WITNESS WHEREOF, the parties have
executed this Agreement as of the Effective Date. 
  

									
	LICENSOR	 		 	LICENSEE
					
	By:	 	 /s/ Asa Lanum
	 		 	By:	 	 /s/ Gary Getz

					
	Name:	 	 Asa Lanum
	 		 	Name:	 	 Gary Getz

					
	Title:	 	 Chief Executive Officer
	 		 	Title:	 	 Chief Executive Officer

			
	Address for Notices	 		 	Address for Notices
			
	 Innovaro, Inc.
	 		 	 Strategos, Inc.

			
	 2109 Palm Avenue
	 		 	 35 East Wacker Drive, Ninth Floor

			
	 Tampa, Florida 33605
	 		 	 Chicago, Illinois 60601

					
	Attn:	 	 Asa Lanum
	 		 	Attn:	 	 Gary Getz

					
	Fax:	 	 (813) 754-2363
	 		 	Fax:	 	 (312) 655-8334

  
 8 

 EXHIBIT A 
 LICENSED TECHNOLOGY 
 The following trade secrets and
know-how: 
  

	1.	Strategic Architecture – method for strategy development. 

  

	2.	(Technology) Futures – method to identify opportunities for the client. 

 

	3.	Innovation Diagnostic – method to assess a company’s enablers and barriers before co-designing a broad innovation program. 

 

	4.	Additional tools, approaches, and frameworks as included in the accompanying Compact Disc. 

  
 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]